Institutional-based tumor registry of hematopoietic malignancies: A 4 years’ preliminary report from Karachi

ABSTRACT

BACKGROUND: Pakistan has a population of over 198 million making it the world’s sixth populous country. However, operational population-based cancer registries in Pakistan are lacking. Limited data are available based on institutional or Karachi Cancer Registry from Karachi; however, no exclusive registry for hematological malignancies is established till date. Hence, we decided to conduct a database analysis to determine the frequencies of various hematological cancers in our tertiary care center in Karachi.

PATIENTS AND METHODS: Retrospective assessment of 366 patients presented to Hematology Department, Liaquat National Hospital and Medical College from May 2012 to May 2016 with confirmed diagnosis of hematological cancers was performed. Data were retrieved from hospital-based tumor registry. All pro forma was filled by qualified medical research officer, which included demographic data as age, gender, history, disease type, and its stage at presentation.

RESULTS: Male gender was predominant and accounted for 69.9% (n = 256) and female accounted for 30.0% (n = 110) of the total cases with the male-to-female ratio of ~2:1. The mean ages of female and male patients were 42.9 ± 20.7 and 49.7 ± 18.1 years with the median age of 45 and 51.5 years, respectively. In males, the three most frequent malignancies were chronic myeloid leukemia (CML) (16%), acute lymphoblastic leukemia (ALL), and acute myeloid leukemia (AML) (12.8% of each). In females, AML was the most common cancer accounting for 21.8% followed by CML (18.1%) and ALL (10%).

CONCLUSIONS: Our institution-based tumor registry indicates CML and AML were the most common cancers in males and females, respectively, followed by ALL. Chronic lymphoid leukemia, unlike in the West, is seen infrequently in our population. National and provisional hematological tumor registry will be beneficial for future health planning and research.

Keywords

Hematological - Karachi - tumor registry

Publication History

Received: 04 April 2017

Accepted: 30 June 2017

Article published online:
19 February 2020

• References

• 1 Kim SY, Park JH, Kang KH, Hwang I, Yang HK, Won YJ, et al. The economic burden of cancer in Korea in 2009. Asian Pac J Cancer Prev 2015;16:1295-301.
• 2 Kanavos P. The rising burden of cancer in the developing world. Ann Oncol 2006;17 Suppl 8:viii15-viii23.
• 3 Talaiezadeh A, Tabesh H, Sattari A, Ebrahimi S. Cancer incidence in southwest of Iran:First report from Khuzestan population-based cancer registry, 2002-2009. Asian Pac J Cancer Prev 2013;14:7517-22.
• 4 Aziz Z, Sana S, Saeed S, Akram M. Institution based tumor registry from Punjab: Five year data based analysis. J Pak Med Assoc 2003;53:350-3.
• 5 Satariano WA, Swanson GM. Racial differences in cancer incidence: The significance of age-specific patterns. Cancer 1988;62:2640-53.
• 6 Masood K, Masood A, Zafar J, Shahid A, Kamran M, Murad S, et al. Trends and analysis of cancer incidence for common male and female cancers in the population of Punjab province of Pakistan during 1984 to 2014. Asian Pac J Cancer Prev 2015;16:5297-304.
• 7 Bal MS, Bodal VK, Kaur J, Kaur M, Sharma S. Patterns of cancer: A study of 500 Punjabi patients. Asian Pac J Cancer Prev 2015;16:5107-10.
• 8 Hanif M, Zaidi P, Kamal S, Hameed A. Institution-based cancer incidence in a local population in Pakistan: Nine year data analysis. Asian Pac J Cancer Prev 2009;10:227-30.
• 9 Jamal S, Atique M, Khadim MT. Changing pattern of malignancies: Analysis of histopathology based tumour registry data and comparison of three decades at Armed Forces Institute of Pathology, Rawalpindi, Pakistan. J Pak Med Assoc 2014;64:24-7.
• 10 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors: Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.
• 11 Bhurgri Y. Karachi Cancer Registry Data – Implications for the National Cancer Control Program of Pakistan. Asian Pac J Cancer Prev 2004;5:77-82.
• 12 Karachi City-Wikipedia, The Free Encyclopedia. Available form: http://www.karachiwikepedia.com. [Last accessed on 2016 Dec 30].
• 13 Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
• 14 Khalid A, Zahid M, Rehman A, Ahmad ZU, Qazi S, Aziz Z. Clinicoepidemiological features of adult leukemias in Pakistan. J Pak Med Assoc 1997;47:119-22.
• 15 Ahmad S, Qureshi AN, Kazmi A, Rasool A, Gul M, Ashfaq M, et al. First cancer statistics report from Hazara division. J Ayub Med Coll Abbottabad 2013;25:71-3.
• 16 National Cancer Institute (NCI), Surveillance, Epidemiology and end Results Program, SEER Stat Facts Sheets, Leukemia. U.S Department of Health and Human Services; 2013.
• 17 Le Guyader-Peyrou S, Belot A, Maynadié M, Binder-Foucard F, Remontet L, Troussard X, et al. Cancer incidence in France over the 1980-2012 period: Hematological malignancies. Rev Epidemiol Sante Publique 2016;64:103-12.
• 18 Clinical Collaborative Group, Hematological Branch of Fujian Medical Association. An epidemiological investigation of adult acute leukemia in Fujian Province in 2010. Zhonghua Xue Ye Xue Za Zhi 2012;33:902-5.
• 19 Clinical Collaborative Group of Fujian Medical Association Hematological Branch. Incidence of newly diagnosed adult acute leukemia in Fujian province from 2011 to 2012. Zhonghua Xue Ye Xue Za Zhi 2015;36:733-8.
• 20 Harani MS, Adil SN, Shaikh MU, Kakepoto GN, Khurshid M. Frequency of fab subtypes in acute myeloid leukemia patients at Aga Khan University Hospital Karachi. J Ayub Med Coll Abbottabad 2005;17:26-9.
• 21 Sultan S, Zaheer HA, Irfan SM, Ashar S. Demographic and clinical characteristics of adult acute myeloid leukemia – Tertiary care experience. Asian Pac J Cancer Prev 2016;17:357-60.
• 22 Shankland KR, Armitage JO, Hancock BW. Non-Hodgkin lymphoma. Lancet 2012;380:848-57.